Potomac Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.85M Hold
117,226
2.15% 14
2023
Q3
$1.01M Hold
117,226
1.29% 20
2023
Q2
$925K Buy
117,226
+12,226
+12% +$85.1K 0.95% 29
2023
Q1
$782K Hold
105,000
0.82% 37
2022
Q4
$1.24M Buy
+105,000
New +$1.2M 1.44% 17

Other funds holding ASPN

Potomac Capital Management's ASPN Position: Q4 2023 in Review

Potomac Capital Management held its Aspen Aerogels (ASPN) position steady in Q4 2023 at 117,226 shares worth $1.85M. The position accounts for 2.15% of the portfolio, ranked #14.

Potomac Capital Management first reported a position in ASPN in Q4 2022 and has held it in 5 quarters since. 170 funds tracked by Wall St. Rank hold ASPN as of Q4 2023.

  • Potomac Capital Management held 117,226 shares of Aspen Aerogels worth $1.85M as of Q4 2023.
  • Potomac Capital Management left its Aspen Aerogels share count unchanged in Q4 2023.
  • Aspen Aerogels made up 2.15% of Potomac Capital Management's portfolio in Q4 2023, its #14 holding.
  • Potomac Capital Management first reported a position in Aspen Aerogels in Q4 2022 and has held it in 5 quarters since.
  • 170 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2023.

Based on Potomac Capital Management's 13F filing for Q4 2023, filed 15 Feb 2024.